EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Emerging measurements for tumor-infiltrating lymphocytes in breast cancer

Rongrong Wu iD, Yoshiya Horimoto iD, Masanori Oshi, Matthew G K Benesch, Thaer Khoury, Kazuaki Takabe, Takashi Ishikawa

Japanese Journal of Clinical Oncology · 01.06.2024 · 54 (6) · 620-629

DOI: 10.1093/jjco/hyae033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Japanese Journal of Clinical Oncology, online erschienen am 23.03.2024. Verfasst von Rongrong Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Tumor Microenvironment, Breast Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Roswell Park Comprehensive Cancer Center, National Cancer Institute Cancer Center Support.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-infiltrating lymphocytes are a general term for lymphocytes or immune cells infiltrating the tumor microenvironment. Numerous studies have demonstrated tumor-infiltrating lymphocytes to be robust prognostic and predictive biomarkers in breast cancer. Recently, immune checkpoint inhibitors, which directly target tumor-infiltrating lymphocytes, have become part of standard of care treatment for triple-negative breast cancer. Surprisingly, tumor-infiltrating lymphocytes quantified by conventional methods do not predict response to immune checkpoint inhibitors, which highlights the heterogeneity of tumor-infiltrating lymphocytes and the complexity of the immune network in the tumor microenvironment. Tumor-infiltrating lymphocytes are composed of diverse immune cell populations, including cytotoxic CD8-positive T lymphocytes, B cells and myeloid cells. Traditionally, tumor-infiltrating lymphocytes in tumor stroma have been evaluated by histology. However, the standardization of this approach is limited, necessitating the use of various novel technologies to elucidate the heterogeneity in the tumor microenvironment. This review outlines the evaluation methods for tumor-infiltrating lymphocytes from conventional pathological approaches that evaluate intratumoral and stromal tumor-infiltrating lymphocytes such as immunohistochemistry, to the more recent advancements in computer tissue imaging using artificial intelligence, flow cytometry sorting and multi-omics analyses using high-throughput assays to estimate tumor-infiltrating lymphocytes from bulk tumor using immune signatures or deconvolution tools. We also discuss higher resolution technologies that enable the analysis of tumor-infiltrating lymphocytes heterogeneity such as single-cell analysis and spatial transcriptomics. As we approach the era of personalized medicine, it is important for clinicians to understand these technologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingTumor MicroenvironmentBreast NeoplasmsHumansFemalePrognosis

Stichwörter der Autor:innen

RNA sequencingTILsbreast cancersingle cellspatial transcriptomics

Autor:innen und Institutionen

  • Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo, Japan.
  • Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Department of Breast Oncology, Juntendo University Hospital, Tokyo, Japan.
  • Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Department of Pathology & Laboratory Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Department of Surgery, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, The State University of New York, Buffalo, NY, USA.

ORCID-Profile: Rongrong Wu, Yoshiya Horimoto

Förderung

  • NCI NIH HHS
  • Roswell Park Comprehensive Cancer Center
  • National Cancer Institute Cancer Center Support
  • NIBIB NIH HHS
  • NIH HHS
  • US Department of Defense BCRP
  • National Institutes of Health

Zitieren

APA

Wu, R., Horimoto, Y., Oshi, M., Benesch, M. G. K., Khoury, T., Takabe, K., & Ishikawa, T. (2024). Emerging measurements for tumor-infiltrating lymphocytes in breast cancer. Japanese Journal of Clinical Oncology, 54(6), 620-629. https://doi.org/10.1093/jjco/hyae033

Vancouver

Wu R, Horimoto Y, Oshi M, Benesch MGK, Khoury T, Takabe K, et al. Emerging measurements for tumor-infiltrating lymphocytes in breast cancer. Japanese Journal of Clinical Oncology. 2024;54(6):620-629. doi:10.1093/jjco/hyae033

BibTeX
@article{Wu2024,
  author = {Wu, Rongrong and Horimoto, Yoshiya and Oshi, Masanori and Benesch, Matthew G K and Khoury, Thaer and Takabe, Kazuaki and Ishikawa, Takashi},
  title = {Emerging measurements for tumor-infiltrating lymphocytes in breast cancer},
  journal = {Japanese Journal of Clinical Oncology},
  year = {2024},
  volume = {54},
  number = {6},
  pages = {620--629},
  doi = {10.1093/jjco/hyae033}
}
Kostenlos starten →